Dr. van Haeringen Laboratorium B.V.

10% discount on our tests

Use the discount code DISCOUNT2020 *

*) For ordering DNA tests and Combination packages in our CombiBreed webshop

This promotion is valid till February 29th 2020, max one discount code per order

H337 Neuronal ceroid lipofuscinosis (NCL) 8-2

Background

Neuronal Ceroid Lipofuscinosis (NCL) is the umbrella term for neurodegenerative diseases due to an excessive accumulation of lipoproteins (lipofuscin) in the tissue. These are waxy waste products of the cell metabolism, which are deposited in the skin, muscles, nerve cells, the retina and many other tissues. The associated damage to the retina can lead to blindness, while the storage of the ceroid lipofuscins in nerve cells impairs their function and a progressive degeneration of the nervous system occurs.

Test specific information

-

Age

Symptoms will develop at a young age. Within a few hours to a maximum of several weeks after birth, the characteristics that go with these genetic effects will become visible.

Turnaround time

The Turnaround Time (TAT) depends on various factors, such as the shipment time of your sample to the test location, the test method(s) and whether the tests are performed completely or partially by a Partner Lab or Patent owner.

The TAT of tests performed at our facilities is normally 10 working days after receipt of the sample at the testing laboratory (VHL, VHP or Certagen). For tests performed by a Partner Laboratory (so-called "partner lab test") or patent owner, the TAT is at least 20 working days after receipt of your sample. Because the shipment time to our Partner Labs or patent owner may vary due to factors we cannot influence, the mentioned 20 working days are therefore an estimate.

PLEASE NOTE
Sometimes it is necessary to re-run your sample. We call this a retest. In that case, the TAT will of course be extended.

Location of disease or trait

This disease is present in the entire body, but causes main effects in the internal organs such as stomach, intestinal tract, liver and / or kidneys. In a number of cases, the disease affects one major internal organ.

Breed dependence

This DNA test is available for the following breeds: Australian Cattle Dog, Australian Shepherd. Additional information is available in the Frequently Asked Questions (FAQ).

Sample type

For this DNA test we accept the following materials: Blood EDTA, Blood Heparin, Semen, Swab, Tissue. Please contact Dr. Van Haeringen Laboratorium if you wish to submit other material as listed.

Result

An animal can be free and has in that situation two healthy alleles. When used in breeding this animal will not become ill due to the disease. It cannot spread the disease in the population.

An animal can be carrier and has in that situation one healthy and one disease allele. When used in breeding 50 percent of the offspring will receive the disease allele. Carriers will not become ill.

An animal can be affected and has in that situation two disease alleles. When used in breeding all offspring will also receive the disease allele. Affected will become ill.

Inheritance

This genetic factor is inherited in an autosomal, recessive, mode. This means, that the individual can be free of the disease (homozygote normal), affected (homozygous affected) or carrier (heterozygous).

Carriers may spread the mutation in a population without showing symptoms themselves. Because of this, it is extremely important to identify carriers correctly to prevent spreading of a mutation.

Severity of Disease

-

Code H337

Neuronal ceroid lipofuscinosis (NCL) 8-2

€ 50,19 (Incl. 21% VAT)
€ 41,48 (Excl. VAT)
Quantity